Yuichi Iida

Engineering precision nanoparticles for drug delivery

Myeloid-derived suppressor cells coming of age

Inflammation and Cancer: Triggers, Mechanisms, and Consequences

Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity

The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth

IL-2 delivery by engineered mesenchymal stem cells re-invigorates CD8+ T cells to overcome immunotherapy resistance in cancer

tRNA genes protect a reporter gene from epigenetic silencing in mouse cells

Systemic delivery of a targeted synthetic immunostimulant transforms the immune landscape for effective tumor regression

Topological domains in mammalian genomes identified by analysis of chromatin interactions

Integration-Free iPS Cells Engineered Using Human Artificial Chromosome Vectors

Structure and Spectroscopy of Copper−Dioxygen Complexes

Myeloid-Derived Suppressor Cells as a Therapeutic Target for Cancer

Copper(I)−Dioxygen Reactivity of [(L)Cu^I]⁺ (L = Tris(2-pyridylmethyl)amine):  Kinetic/Thermodynamic and Spectroscopic Studies Concerning the Formation of Cu−O₂ and Cu₂−O₂ Adducts as a Function of Solvent Medium and 4-Pyridyl Ligand Substituent Variations

Nanoparticle-Mediated Co-Delivery of Notch-1 Antibodies and ABT-737 as a Potent Treatment Strategy for Triple-Negative Breast Cancer

Human Artificial Chromosome with a Conditional Centromere for Gene Delivery and Gene Expression

Contrasting effects of cyclophosphamide on anti‐CTL‐associated protein 4 blockade therapy in two mouse tumor models

Bcl-2 inhibition sensitizes triple-negative human breast cancer cells to doxorubicin

In-plane ligand effects on oxygenation of cobalt(II) schiff base complexes

Local injection of CCL19-expressing mesenchymal stem cells augments the therapeutic efficacy of anti-PD-L1 antibody by promoting infiltration of immune cells